Vectorite Biomedical (ROCO:4170) Long-Term Debt: NT$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4170 Vectorite Biomedical Inc ROCO:4170
64 GF Score
Price NT$12.10
GF Value NT$17.66
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Vectorite Biomedical Long-Term Debt?

Vectorite Biomedical ROCO:4170 +5.22% 64 Long-Term Debt is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:4170 with a GF Score™ of 64/100 and a GF Value™ of NT$17.66 (Possible Value Trap). The stock has 4 warning signs investors should review.

Vectorite Biomedical's Long-Term Debt for the quarter that ended in Dec. 2025 was NT$0.00 Mil.

Vectorite Biomedical  (ROCO:4170) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Vectorite Biomedical Long-Term Debt Related Terms

Vectorite Biomedical Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Vectorite Biomedical's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vectorite Biomedical Long-Term Debt Chart

Vectorite Biomedical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vectorite Biomedical Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:4170
64GF Score
Vectorite Biomedical Inc ROCO:4170
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of NT$0.00 Mil mean?
Vectorite Biomedical (ROCO:4170) has a Long-Term Debt of NT$0.00 Mil as of Dec. 2025.
Is Vectorite Biomedical's Long-Term Debt too high?
Vectorite Biomedical's current Long-Term Debt is NT$0.00 Mil. Overall, Vectorite Biomedical has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vectorite Biomedical's Long-Term Debt compare to VRTX and REGN?
Vectorite Biomedical's Long-Term Debt of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Vectorite Biomedical's current Long-Term Debt is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vectorite Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Vectorite Biomedical (ROCO:4170) is currently considered Possible Value Trap. The stock's GF Value™ is NT$17.66, compared to a current price of NT$12.10 — trading 31.5% below its estimated fair value. The current Long-Term Debt is NT$0.00 Mil. Vectorite Biomedical's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Vectorite Biomedical (ROCO:4170), the current Long-Term Debt is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vectorite Biomedical (ROCO:4170) Overvalued in 2026?

Based on GuruFocus' analysis, Vectorite Biomedical stock appears to be undervalued. The current stock price of NT$12.10 is trading 31.5% below its estimated GF Value™ of NT$17.66. GuruFocus considers Vectorite Biomedical to be Possible Value Trap.

Key valuation signals for ROCO:4170:

  • Long-Term Debt: NT$0.00 Mil
  • GF Value™: NT$17.66 vs. price of NT$12.10 (31.5% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4170 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vectorite Biomedical Business Description

Address Number 97, Section 1, Xintai 5th Road, 6th Floor, Floor-11, Yuzhi District, New Taipei City, Taipei, TWN, 22175
Vectorite Biomedical Inc is a Taiwan-based biotechnology research and development, cell product (preparation) manufacturing and immune cell collection and storage business.
64GF Score

Get the complete analysis for ROCO:4170

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$12.10
Price
NT$17.66
GF Value